Drug shortage
For Solution · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · Current · updated Oct 1, 2026
Key facts
| Generic name | For Solution, Streptozocin Powder |
|---|---|
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01) |
| Dosage form | For Solution, Powder |
| Status | Current |
| Reason for shortage | Other |
| Therapeutic category | Oncology |
| Package NDCs | 0703-4636-01 |
| First posted | Jul 12, 2022 |
| Last updated | Oct 1, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: